Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001237894 | SCV001410681 | likely pathogenic | H syndrome | 2022-08-15 | criteria provided, single submitter | clinical testing | In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. Algorithms developed to predict the effect of missense changes on protein structure and function (SIFT, PolyPhen-2, Align-GVGD) all suggest that this variant is likely to be disruptive. ClinVar contains an entry for this variant (Variation ID: 963811). This missense change has been observed in individual(s) with SLC29A3-related disease (PMID: 24172204, 29808591; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. This variant is present in population databases (rs758201217, gnomAD 0.05%). This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 324 of the SLC29A3 protein (p.Pro324Leu). |
Fulgent Genetics, |
RCV001237894 | SCV002805561 | likely pathogenic | H syndrome | 2022-03-27 | criteria provided, single submitter | clinical testing |